Rewind Therapeutics

Foundation date

27/09/2017

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

We discover and develop innovative first-in-class remyelinating therapies for patients suffering from multiple sclerosis and other myelin-related diseases.

Upcoming events

Latest news

  • Tom Plitz commences role as Chief Executive Officer of Precirix

    Friday March 1st 2024

  • Newly discovered protein blocks sleeping sickness

    Wednesday February 28th 2024

  • DONESTA┬« safety study for menopause completes treatment phase and advances to data management & reporting phase

    Wednesday February 28th 2024